TABLE 3.
Meta-regression Analysis for the Incidence of HO
| Meta-regression coefficient | 95% CI | P | |
|---|---|---|---|
| Overall HO | |||
| Year of publication | −0.06 | −0.19 to 0.07 | 0.301 |
| Age | 0.02 | −0.02 to 0.06 | 0.218 |
| Male sex | −0.19 | −2.32 to 1.95 | 0.845 |
| Design (retrospective vs. prospective) | −0.07 | −0.42 to 0.27 | 0.645 |
| Prosthesis type | |||
| Prestige LP vs. others | −0.13 | −0.54 to 0.27 | 0.470 |
| Prodisc-C vs. others | 0.27 | −0.07 to 0.61 | 0.106 |
| Bryan vs. others | −0.14 | −0.52 to 0.24 | 0.431 |
| Funding source | 0.137 | −0.29 to 0.56 | 0.487 |
| CDR at C5/6 | −0.78 | −2.33 to 0.77 | 0.264 |
| ROM-pre | 0.017 | −0.14 to 0.18 | 0.788 |
| ROM 10-year | −0.05 | −0.39 to 0.29 | 0.706 |
| ASD | −0.34 | −2.03 to 1.34 | 0.634 |
| Severe HO | |||
| Year of publication | −0.27 | −0.47 to −0.06 | 0.015 * |
| Age | 0.01 | −0.10 to 0.11 | 0.906 |
| Male sex | −0.38 | −4.89 to 4.13 | 0.853 |
| Design (retrospective vs. prospective) | −0.24 | −0.92 to 0.45 | 0.460 |
| Prosthesis type | |||
| Prestige LP vs. others | −0.03 | −0.89 to 0.82 | 0.930 |
| Prodisc-C vs. others | 0.37 | −0.46 to 1.17 | 0.347 |
| Bryan vs. others | −0.33 | −1.09 to 0.42 | 0.346 |
| Mobi-C vs. others | 0.15 | −1.17 to 1.46 | 0.805 |
| Funding source | 0.10 | −0.70 to 0.90 | 0.787 |
| CDR at C5/6 | −0.58 | −4.10 to 2.93 | 0.698 |
| ROM-pre | −0.11 | −0.60 to 0.37 | 0.567 |
| ROM 10 yr | −0.31 | −0.70 to 0.07 | 0.091 |
| ASD | −0.80 | −3.43 to 1.82 | 0.492 |
P-value<0.05.
ASD indicates adjacent segment degeneration; CDR, cervical disk replacement; HO, heterotopic ossification; ROM, range of motion.